275 related articles for article (PubMed ID: 14999937)
1. [Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
Yasuyama M; Kawauchi K; Takei K; Ogasawara T; Ohkawa S
Rinsho Ketsueki; 2004 Jan; 45(1):66-71. PubMed ID: 14999937
[TBL] [Abstract][Full Text] [Related]
2. [Myositis caused by hydroxyurea in a patient with chronic myelogenous leukemia].
Ikeda K; Mita M; Ishibashi T; Shichishima T; Maruyama Y
Rinsho Ketsueki; 1998 Sep; 39(9):676-9. PubMed ID: 9796402
[TBL] [Abstract][Full Text] [Related]
3. [One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
Kobayashi Y; Kimura S; Tanaka K; Kimura S; Wada K; Ozawa M; Maruo N; Kondo M
Rinsho Ketsueki; 1990 Jul; 31(7):1013-6. PubMed ID: 2214181
[TBL] [Abstract][Full Text] [Related]
4. Philadelphia negative, Bcr-Abl positive chronic myeloid leukemia associated with pure red cell aplasia.
Karti S; Yilmaz M; Sonmez M; Akdogan R; Ersoz S; Ucar F; Ovali E
J Exp Clin Cancer Res; 2003 Jun; 22(2):341-2. PubMed ID: 12866588
[TBL] [Abstract][Full Text] [Related]
5. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
[TBL] [Abstract][Full Text] [Related]
6. [Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
Koike G; Otsuka T; Shibuya T; Niho Y
Rinsho Ketsueki; 1989 Mar; 30(3):400-3. PubMed ID: 2769964
[TBL] [Abstract][Full Text] [Related]
7. [Chronic myelogenous leukemia following therapy for pineal germinoma].
Noda M; Shoda T; Takimoto Y; Okita H
Rinsho Ketsueki; 2004 Jan; 45(1):72-4. PubMed ID: 14999938
[TBL] [Abstract][Full Text] [Related]
8. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
[TBL] [Abstract][Full Text] [Related]
9. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
Hayden PJ; Gardiner N; Molloy K; Ryan J; Lawler M; McCann SR
Bone Marrow Transplant; 2004 Feb; 33(4):459-61. PubMed ID: 14676777
[No Abstract] [Full Text] [Related]
10. [Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].
Hasegawa A; Ninomiya H; Yanagisawa K; Takada K; Hasegawa H; Hato T; Yasukawa M; Fujita S
Rinsho Ketsueki; 1996 Sep; 37(9):853-7. PubMed ID: 8914475
[TBL] [Abstract][Full Text] [Related]
11. [Embolization of the bilateral internal pudendal arteries for intractable priapism in a child with chronic myelogenous leukemia].
Murayama K; Shibuya A; Ishii S; Sasaki N
Rinsho Ketsueki; 2001 Nov; 42(11):1117-21. PubMed ID: 11808081
[TBL] [Abstract][Full Text] [Related]
12. [Erythrocyte cell aplasia in chronic myeloid leukemia--coincidence or pathogenic link].
Tukić L; Malesević M; Krstić C; Lakić-Trajković Z; Cik Z
Med Pregl; 1990; 43(1-2):32-6. PubMed ID: 2120556
[TBL] [Abstract][Full Text] [Related]
13. [Chronic myelogenous leukemia with marked thrombocytosis].
Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia].
Furuya H; Wakayama T; Tanaka J; Tsumori M; Hatazoe T; Ohguni S; Sato T; Ishikura H; Kato Y
Rinsho Ketsueki; 1995 Nov; 36(11):1279-83. PubMed ID: 8691568
[TBL] [Abstract][Full Text] [Related]
15. [Chronic myelocytic leukemia induced into remission by interferon-alpha associated with early esophageal cancer].
Annoh S; Umeda M; Arai N; Shikoshi K; Su CY; Yasushi T; Kitazawa Y; Shirai T
Rinsho Ketsueki; 1991 Jul; 32(7):786-90. PubMed ID: 1920843
[TBL] [Abstract][Full Text] [Related]
16. Delayed spontaneous remission in a child with primary acquired chronic pure red cell aplasia.
Khalil A; Elhasid R; Ben Barak A; Ben Arush MW
Pediatr Hematol Oncol; 2010 Oct; 27(7):574-80. PubMed ID: 20615070
[TBL] [Abstract][Full Text] [Related]
17. [Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia].
Koyama S; Aoki S; Furukawa T; Takahashi M; Kishi K; Koike T; Moriyama Y; Hattori A; Shibata A
Rinsho Ketsueki; 1991 Dec; 32(12):1577-9. PubMed ID: 1779460
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of alpha interferon and hydroxyurea in late phase refractory myeloproliferative disease.
Litam PP; Landaw SA; Zamkoff KW
Haematologia (Budap); 1994; 26(2):87-90. PubMed ID: 7890266
[TBL] [Abstract][Full Text] [Related]
19. [Management of complications in patients with chronic myelogenous leukemia].
Yoshida M
Nihon Rinsho; 2001 Dec; 59(12):2410-5. PubMed ID: 11766348
[TBL] [Abstract][Full Text] [Related]
20. [Pure red-cell aplasia associated with chronic myeloproliferative syndromes].
Villarrubia J; Pascual C; Pérez Vaquero MA; Escribano L; Bellas C; Orte J; Heinrichs B; Velasco JL
Med Clin (Barc); 1992 Feb; 98(4):139-41. PubMed ID: 1552765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
